Skip to content

MANAGEMENT OF PSORIASIS WITH AYURVEDA FORMULATION

CLINICO COMPARATIVE STUDY OF LELĪTAKA-MÄ?Ká¹¢IKA YOGA AND KAIÅ?ORA GUGGULU -MAÃ?JIṢṬHÄ?DI KVÄ?THA IN THE MANAGEMENT OF EKAKUṢṬA (PSORIASIS)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016594
Enrollment
30
Registered
2018-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: LELITAK MAKSHIK YOGA: IT IS IN TABLET FORM OF 500 MG EACH TABLET. DOSE OF IT WILL BE OF 1 GM TWO TIMES IN A DAY WITH WATER Control Intervention1: KAISHORA GUGGULU TABLET AND MAJISTHADI

Sponsors

J S AYURVED MAHAVIDYALAYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Asvedana (loss of perspiration) 2. Mahavastu / Mandala (lesions distibution) 3. Matsyasakalopama (Scaling) 4. Krsna aruna varna / Abhrakpatrasama (Discoloration) 5. Kandu (Itching) 6. Ruksata (Dryness) Following any one of this sign 1. Auspitz,s sign 2. Candle grease sign 3. Koebner,s phenomenon

Exclusion criteria

Exclusion criteria: 1. Female patients have pregnancy or lactating period. 2. Patient with associated disease like cardiovascular disorders, hyperthyroidism or hypothyroidism, cancer, tuberculosis, heart diseases, psoriatic arthritis, kidney and liver disorders. 3. Patients having HbA1c above 7.5 of diabetes mellitus. 4. Patients who have taken medication of corticosteroids, drugs within last 6 months.

Design outcomes

Primary

MeasureTime frame
CHANGES IN SIGNS AND SYMPTOMS OF PSORIASISTimepoint: 8 WEEKS

Secondary

MeasureTime frame
PSORIASIS AREA AND SEVERITY INDEX DERMATOLOGY QUALITY LIFE INDEXTimepoint: O DAY, 4WEEKS AND 8 WEEKS

Countries

India

Contacts

Public ContactVIGNA RAJENDRABHAI VYAS

J S AYURVED MAHAVIDYALAYA

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026